Page 190 - Orange Book Cumulative Supplement 10 October 2012

B-1

PATENT AND EXCLUSIVITY TERMS

Due to space limitations in the patent and exclusivity columns,
abbreviations and references have been developed. Refer to the APPROVED DRUG
PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS, 31 st Edition for a full listing of
patent and exclusivity terms (Abbreviations, Dosing Schedule, Indications,
and Patent Use Codes).

The current complete list of patent terms is available at
http://www.accessdata.fda.gov/scripts/cder/ob/docs/pattermsall.cfm

The current complete list of patent terms is available at
http://www.accessdata.fda.gov/scripts/cder/ob/docs/excltermsall.cfm